Effects of Insulin on Methionine and Homocysteine Kinetics in Type 2 Diabetes With Nephropathy

Abstract

Although hyperhomocysteinemia, an independent cardiovascular risk factor, is common in type 2 diabetes with nephropathy, the mechanism(s) of this alteration is not known. In healthy humans, hyperinsulinemia increases methionine transmethylation, homocysteine transsulfuration, and clearance. No such data exist in type 2 diabetes either in the fasting state or in response to hyperinsulinemia. To this purpose, seven male type 2 diabetic patients with albuminuria (1.2 ؎ 0.4 g/day, three with mild to moderate renal insufficiency) and seven matched control subjects were infused for 6 h with L-[methyl-2 H 3 , 1-13 C]methionine. Methionine flux, transmethylation, and disposal into proteins as well as homocysteine remethylation, transsulfuration, and clearance were determined before and after euglycemic hyperinsulinemia (ϳ1,000 pmol/l). In type 2 diabetic subjects, homocysteine concentration was twofold greater (P < 0.01) and methionine transmethylation and homocysteine clearance lower (from ϳ15 to >50% and from ϳ40 to >100%, respectively; P < 0.05) than in control subjects. The insulin-induced increments of methionine transmethylation, homocysteine transsulfuration, and clearance were markedly reduced in type 2 diabetic subjects (by more than threefold, P < 0.05 or less vs. control subjects). In contrast, methionine methyl and carbon flux were not increased in the patients. In conclusion, pathways of homocysteine disposal are impaired in type 2 diabetes with nephropathy, both in postabsorptive and insulin-stimulated states, possibly accounting for the hyperhomocysteinemia of this condition. Diabetes

Folate status modulates the induction of hepatic glycineN-methyltransferase and homocysteine metabolism in diabetic rats

“…Ultimately, studies that focus on the measurement of metabolic flux through these pathways, similar to what has been recently reported (10,11), needs to be performed to definitively evaluate the effect of diabetes. Recently, a kinetic study with human subjects (51) demonstrated that transmethylation, homocysteine transsulfuration, and clearance of homocysteine were significantly reduced in type 2 diabetes with nephropathy.…”

Hydrogen sulfide ameliorates hyperhomocysteinemia-associated chronic renal failure

“…In disease condition, such as in diabetic nephropathy, Hcy disposal and clearance are impaired and therefore accumulate in the body, resulting in increase of plasma and tissue levels of Hcy (43). This, in turn, causes renal microvascular impairment and vasoconstriction (37), which lead to renal volume retention and further accumulation of Hcy (38).…”

Tissue methionine cycle activity and homocysteine metabolism in female rats: impact of dietary methionine and folate plus choline

“…In humans, studies in vivo have been restricted to plasma kinetics (1,24,37) but without knowing if these reflect common responses across all tissues or are dominated by just a few organs. From more detailed studies in rodents, liver, kidney, and pancreas are considered the main sites of methionine cycle activity, based on measurements in vitro of the enzyme activities of betaine homocysteine methyltransferase (BHMT) and methionine synthase (MS; N-5-methyltetrahydrofolate transferase) (41), but this does not mean they have the same end points of homocysteine metabolism.…”